Skip to main content

C-RAD is expanding the sales organization and the support to the North American market

Press release 2010-06-23
C-RAD is expanding the sales organization and the support to the North American 
C-RAD AB with its three fully owned subsidiaries is active in the field of      
radiation therapy. To further increase the market presence on the important US  
and Canadian markets C-RAD is starting up a representative office.     
C-RAD is developing and marketing systems for use in radiation therapy to       
improve precision and effectiveness when treating patients. C-RAD Sentinel is a 
laser scanner system detecting the surface of the patient. C-RAD GEMini is based
on the unique GEM technology to be used both as a diagnostic X-ray and a portal 
imaging device. Almost fifty percent of the potential market for these systems  
are in the US and Canada. USA has also become the most important market for     
sales of Sentinel systems.     
To further increase sales and support to US and Canadian customers C-RAD has    
decided to open its own representative office in the US. Mr. Daniel O´Connell   
has been appointed regional sales manager for the North American market. He has 
a long experience in the field of radiation therapy and to work with customers  
both domestically and internationally. During last years he has as an           
application specialist been working nationwide and supporting international     
sales for the Elekta group.                                                     

Erik Hedlund, CEO, C-RAD AB:                                                    
”Based on sales in the US last 12 months, it is a natural to further invest in a
C-RAD representative office. We are pleased to welcome Daniel O´Connell to our  
team. We expect, through his network and expertise, to further develop our      
presence in the region. Daniel will work closely with our distributors Radiation
Oncology Systems and Acceletronics.”                                            

Daniel O´Connell, C-RAD regional sales manager North America:                   
“I am really excited to join the C-RAD team, enabling me to offer truly         
innovative, state-of the art solutions to the North American Medicine Market. It
is a natural evolution following many years of successfully activities in both  
North America and internationally.”                                             

For further information:                                                        
Erik Hedlund, CEO C-RAD AB, Telefon 018 - 66 69 31, E-post

About C-RAD AB                                                                  
C-RAD develops new and innovative solutions for the use in advanced radiation   
therapy. The company group of C-RAD offers products and solutions for patient   
positioning, tumor localization and radiation treatment systems. End users are  
radiation therapy clinics worldwide. All product development is conducted in    
three fully owned subsidiaries; C-RAD Positioning AB, C-RAD Imaging AB and C-RAD
Innovation AB. C-RAD Imaging AB is located in Östersund while the other         
companies are located in Uppsala. Numbers of employees are currently 19 people. 
The activities in C-RAD AB originate from research and development at the       
Karolinska Institutet in Solna. Sales of the company's first product, the C-RAD 
SentinelTM, started in 2007. Cooperation agreements have been signed with the   
Swedish company Elekta and the Belgian company IBA. C-RAD is represented by     
distributors specialized in radiation therapy on major markets. C-RAD AB is     
since March 2010 listed at Nasdaq Omx First North Premier.
Close Menu